kainos loboratories,inc (4556) Other
Market cap
¥10.4B
P/E ratio
16x
Kainos manufactures diagnostic pharmaceuticals, laboratory reagents, and medical devices for hospitals and research facilities to improve healthcare quality.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 4.9 | 5.3 | 4.7 | 6.4 | 6.3 | 6.1 | 7.1 | 7.2 | 7.6 | 7.4 | 4.9 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 160 | 159 | 166 | 158 | 164 | 162 | 158 | 159 | 163 | 154 | 149 | 144 | 146 | 157 | - |
| Total payout ratio | - | - | - | 14.7 | 108.6 | 34.2 | - | 154.8 | - | 37.8 | 43.7 | 19.7 | - | - | - |